1. Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study. (25th November 2020) Authors: Calcaterra, I; Di Minno, A; Gentile, M; Tripaldella, M; Buonaiuto, A; Forte, F; Di Taranto, M.D; Giacobbe, C; Iannuzzo, G; Rubba, P.O.F; Di Minno, M.N.D Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report. (25th November 2020) Authors: Buonaiuto, A; Gentile, M; Calcaterra, I.L; Giacobbe, C; Tripaldella, M; Forte, F; Iannuzzo, G; Di Minno, M.N.D; Fortunato, G; Rubba, P.O.F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗